Superiority of Iodine-123 Compared with Iodine-131 scanning for thyroid remnants in patients with differentiated thyroid cancer

Clinical Nuclear Medicine

Volumn 26, Issue 1, 2001, Pages 6-9

  Mandel, Susan J ^a,b   Shankar, Lalitha K ^a   Benard, Francois ^a   Yamamoto, Alvin ^a   Alavi, Abass ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

I 123; I 131; Radioactive Iodine; Thyroid Cancer

Indexed keywords

IODINE 123; IODINE 131; RADIOACTIVE IODINE;

ADULT; ARTICLE; CLINICAL ARTICLE; COLLIMATOR; DIAGNOSTIC IMAGING; DIFFERENTIATION; DRUG HALF LIFE; DRUG UPTAKE; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; SCINTILLATION CAMERA; THYROID CANCER; THYROID SCINTISCANNING; THYROIDECTOMY; WHOLE BODY SCINTISCANNING;

ADENOCARCINOMA, FOLLICULAR; ADULT; CARCINOMA, PAPILLARY; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; NEOPLASM, RESIDUAL; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 0035190375     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200101000-00002     Document Type: Article

References (7)

1. Influence of initial large dose on subsequent uptake of therapeutic radioiodine in thyroid cancer patients
2. Influence of diagnostic radioiodines on the uptake of ablative dose of I-131
3. Radioiodine uptake in thyroid cancer patients after diagnostic application of low-dose I-131
4. Decreased uptake of therapeutic doses of iodine-131 after 185-MBq iodine-131 diagnostic imaging for thyroid remnants in differentiated thyroid carcinoma
5. Detection of thyroid remnant/metastasis without stunning: An ongoing dilemma
6. Use of iodine-123 as a diagnostic tracer for neck and whole-body scanning in patients with well-differentiated thyroid cancer
7. Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma